Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 4/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
| ▸ | ADH1A | P07327 | 1/20 | 0.35 |
| ▸ | ADH4 | P08319 | 1/20 | 0.35 |
| ▸ | ADH7 | P40394 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10643424 | 0.86 | EPHX1 (0.48) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL28101186 | 0.86 | EPHX1 (0.48) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL28101271 | 0.82 | EPHX1 (0.48) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL27738542 | 0.82 | EPHX1 (0.48) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL24307452 | 0.81 | SPHK1 (0.45) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL4186116 | 0.81 | SPHK1 (0.45) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL11805294 | 0.81 | EPHX1 (0.40) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL28588484 | 0.81 | LMNA (0.45) | OPRM1FDPSSPHK1EPHX1LMNA | |
| SCHEMBL24072015 | 0.79 | OPRM1 (0.44) | OPRM1FDPSSPHK1LMNADNM1 | |
| Hydrochloric Acid SCHEMBL11189185 | 0.79 | DNM1 (0.44) | OPRM1FDPSSPHK1EPHX1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9603787-B2 | Sunscreen formulations comprising Gemini surfactants and silicone based surfactants | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) | 2017-03-28 | — | — | US | disclosed |
| US-20160166496-A1 | Sunscreen Formulations Comprising Gemini Surfactants and Silicone Based Surfactants | AKZO NOBEL CHEMICALS INTERNATIONAL B.V. | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166496-A1 | Sunscreen Formulations Comprising Gemini Surfactants and Silicone Based Surfactants | GSS, LAGE3, SMURF1 | OPRM1 4201/4885FDPS 2579/4885SPHK1 945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.